Navigation Links
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association

* Ozarelix Effective in Improving Symptoms and Urine Flow, With Long Lasting Effect in Phase 2 Study

IRVINE, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc., today announced Phase 2 safety and efficacy data for ozarelix, the Company's drug candidate for the treatment of benign prostatic hypertrophy (BPH), at the American Urology Association Annual Meeting held at the Anaheim Convention Center in Anaheim, California on Tuesday, May 22, 2007.

"The results of this study indicate a significant and sustained degree of benefit, higher than what is usually seen with current treatments of BPH," said Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals. "We have recently completed enrollment in a Phase 2b study in the U.S. Once we have preliminary results from this Phase 2b trial, we plan to begin a Phase 3 trial, which we expect to begin later this year. Results from the Phase 2b trial will aid in the design of the Phase 3 trial. We believe that ozarelix could help serve the large unmet medical need for more effective BPH treatments."

The efficacy and safety of ozarelix, a GnRH antagonist, given intramuscularly (IM) was assessed in men with moderate to severe Lower Urinary Tract Symptoms (LUTS) due to BPH in a randomized, double-blind, placebo- controlled, multi-center, Phase 2 dose-ranging study.

Patients (N=144) meeting the inclusion criteria were randomly allocated to one of five treatment groups:

    Group 1:  placebo,

    Group 2:  5mg ozarelix on Day 1 + 5mg ozarelix on Day 15;

    Group 3:  10mg ozarelix on Day 1 +10mg ozarelix on Day 15;

    Group 4:  15mg ozarelix on Day 1 + 15mg ozarelix on Day 15; and,

    Group 5:  20mg ozarelix on Day 1 only.

Study participants were followed for six months. The primary efficacy endpoint was a change in the International Prostate Symposium Score (IPS
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "North ... & Graft), by Application (Surgical Wound, & Ulcer), ... Forecast to 2019" report to their offering. ... wound care market is estimated to grow at ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
... Sept. 21 The Association of Medical Media (AMM) ... highest-scoring medical journal advertisements Thursday, September 16, 2010.   ... annual study developed by AMM, researches physician attitudes toward ... 21 specialties from the 86 most widely-advertised products in ...
... More than one in three diabetes patients skip doses ... they have done so on average three times in the ... reality this number could be as high as six doses*, ... Insulin Therapy (GAPP™) survey, released today by Novo Nordisk. ...
Cached Medicine Technology:AMM Names 2010 Doctors' Choice Awards Winners 2AMM Names 2010 Doctors' Choice Awards Winners 3New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 2New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 3
(Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Dr. David Benvenuti, ... has just posted a new article to his ... As Dr Benvenuti explained in the fascinating blog, ... plugs in their earlobes. , Known as “gauging,” the technique ... hole, which Dr. Benvenuti said will eventually stretch the holes ...
(Date:5/23/2015)... A live auction will be held to sell ... and other medical facilities around the United States. Various ... surgery, anesthesia, exam and much more. , The live ... 28 starting at 9:00am CDT each day. The equipment is ... Melrose Park, IL 60160. Anyone can participate in the ...
(Date:5/22/2015)... 2015 Pioneer Millworks, the largest reclaimed ... of designing with reclaimed wood, introducing their latest reclaimed ... California. Their newest offerings, Vat 35, Reclaimed Teak ... color to America's largest design event. , “Designers, architects, ... show, anxious to see and feel the variety of ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... shows that the prevalence of hay fever and eczema in ... risen sharply.// ,In the research that has been ... the University of Edinburgh have said that the rates of ... years of steady rise but at the same time allergic ...
... of developing lymphoma and leukemia. The autoimmune, inflammatory disease ... the risk of cancer. //Researchers speculate that antirheumatic drugs ... a type of biologic DMARD may play a role ... attaching to and impeding chemical messengers behind inflammation, have ...
... Researchers say that in Asian children must be given Vitamin ... order to avert the reappearance of deficiency symptoms. //Researchers examined ... and have published their findings in the latest issue of ... can cause rickets, poor tooth formation, convulsions, general ill health, ...
... who carried donor cards no longer have the last say ... new laws will come into force that will make the ... carry a donor card, their relatives can prevent doctors from ... reported to do so. ,The new laws have come into ...
... in traumatic head injuries among Canadians under age 19 ... released on Wednesday.// ,When the Canadian Institute for ... injuries from 1994 to 2004 it found that overall, ... with children and youth showing the largest drop. ...
... are genetically more suited to being vegetarians than meat-eaters is ... by more then 300 leading scientists from New Zealand and ... a cure for cancer is also under discussion at the ... of the conference says the finding that a human is ...
Cached Medicine News:Health News:Eczema And Hay Fever Decline In UK While Allergic Reactions On The Rise 2Health News:RA Drugs Not Implicated In Cancer 2Health News:Asian Children Need More Vitamin D Supplements 2Health News:Families of the Dead no Longer Have the Last Say 2Health News:Families of the Dead no Longer Have the Last Say 3
... amplifier in the world. ,XLTEK EEG ... for accurate data acquisition with 500 Hz ... the highest signal-to-noise ratios available and fast ... All of this is for one purpose ...
... The cold-light illumination can be used ... the Head-worn Loupe KF Titanium and the ... the almost coaxial illumination, even in unfavorable ... The flexible, lightweight liquid light guide ensures ...
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
... from Bausch & Lomb provides fingertip control ... one handed delivery of the IOL directly ... bag is assured by planar delivery. Leading ... into the capsular bag without sweeping motion. ...
Medicine Products: